Short description
MicroBPlex is developing a diagnostic platform to identify microbial infections.
Description
MicroBPlex is developing a diagnostic platform to identify microbial infections, particularly pneumonia and influenza. The diagnostic uses a matrix of newly synthesized antibodies that are secreted by specialized Antibody Secreting Cells (ASCs) that circulate in a patient’s blood during acute infections.
Total funding
$$3123123
Sign in for full access
Location
Atlanta, Georgia, United States, North America
Founded on
January 1, 2011
Non-profit?
No
Acquired?
No
Revenue range
$1230 - 4560
Sign in for full access
Investors
Absolutely Noaccess
Sign in for full access
Founders
Frances Eun-Hyung Lee, John L. Daiss